Last updated: January 18, 2025
Sponsor: Sebahattin Celik MD
Overall Status: Completed
Phase
2/3
Condition
Obesity
Diabetes Prevention
Treatment
botulinum toxin A injection
gastric balloon implantation
Clinical Study ID
NCT05872932
2023-15/03/1374
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patients with body mass index over 30
patients who have been on a diet and have done sports at least for 6 month and yetcould not lose weight.
18-65 years old patients
Exclusion
Exclusion Criteria:
patients diagnosed with peptic ulcer
untraceable patients after injection of botulinum toxin A
patients with no history of bariatric surgery or interventions
patients who do not retrieve balloon after 6 month or require repetitiveimplantations.
Study Design
Total Participants: 131
Treatment Group(s): 2
Primary Treatment: botulinum toxin A injection
Phase: 2/3
Study Start date:
December 30, 2023
Estimated Completion Date:
December 30, 2024
Connect with a study center
Yuzuncu Yil University Faculty of Medicine
Van, 65080
TurkeySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.